Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.
about
Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Expanded safety analysis of pe ...... and myelodysplastic syndromes.
@en
Expanded safety analysis of pe ...... and myelodysplastic syndromes.
@nl
type
label
Expanded safety analysis of pe ...... and myelodysplastic syndromes.
@en
Expanded safety analysis of pe ...... and myelodysplastic syndromes.
@nl
prefLabel
Expanded safety analysis of pe ...... and myelodysplastic syndromes.
@en
Expanded safety analysis of pe ...... and myelodysplastic syndromes.
@nl
P2093
P2860
P356
P1433
P1476
Expanded safety analysis of pe ...... and myelodysplastic syndromes.
@en
P2093
B C Medeiros
B J Dezube
D J DeAngelo
F Sedarati
J K Altman
P2860
P2888
P356
10.1038/BCJ.2017.1
P50
P577
2017-02-03T00:00:00Z
P6179
1083525975